Xos, Inc. SEC Filings

Emerald Green Trust, identified as a reporting person for Xos, Inc. (XOS), reported a sale of 7,922 shares of XOS common stock on 09/12/2025 under a previously established Rule 10b5-1 trading plan. The reported weighted-average sale price was $2.3901, with individual sale prices ranging from $2.37 to $2.42. Following the reported sale, the filing shows the reporting person beneficially owns 1,574,212 shares of common stock as a direct owner. The filing was signed by Sarah Bardo, Trustee for Emerald Green Trust.

The filing shows Emerald Green Trust, identified as a director of Xos, Inc. (XOS), reported a series of open-market sales executed under a Rule 10b5-1 trading plan adopted May 27, 2025. Sales occurred on Sept 9–11, 2025, totaling 24,788 shares sold in three transactions at weighted average prices of $2.2762, $2.3463, and $2.3876, respectively. After these transactions the trust reported beneficial ownership of 1,582,134 shares direct. The report is signed by Sarah Bardo, Trustee. The filer discloses price ranges for each sale date and offers to provide per-price details upon request.

Xos, Inc. (XOS) filed a Form 144 notifying the proposed sale of 200,000 shares of common stock, with an aggregate market value of $468,000, to be sold through Piper Sandler on 09/11/2025. The filing shows these shares were acquired on 08/20/2021 as SPAC merger shares from the issuer.

The notice also discloses significant recent sales by the selling account: 196,628 shares were sold across multiple dates between 08/26/2025 and 09/10/2025, generating approximately $542,622.67 in gross proceeds. Outstanding shares are listed as 10,493,845, so the proposed 200,000-share sale represents roughly 1.9% of that total. The filer certifies no undisclosed material adverse information.

Xos, Inc. is registering 4,160,005 additional shares of common stock for issuance under its Amended and Restated 2021 Equity Incentive Plan. This total includes 3,100,000 new shares added by a 2025 Amendment approved by the board on May 9, 2025 and by stockholders on June 24, 2025. It also includes 402,314 shares from the plan’s automatic share increase on January 1, 2025, plus 407,296 shares from forfeited restricted stock units and 250,395 shares tied to restricted stock units previously withheld to cover tax obligations as of July 31, 2025. The filing updates the existing S-8 registrations for this equity compensation plan by incorporating prior registration statements and recent periodic reports by reference.

Emerald Green Trust, reporting as a director and 10% owner of Xos, Inc. (XOS), disclosed routine insider sales executed under a Rule 10b5-1 trading plan adopted May 27, 2025. The Form 4 reports three non-derivative sales of common stock: on 09/04/2025 the trust sold 13,110 shares at a weighted-average price of $2.2758 leaving 1,624,087 shares; on 09/05/2025 it sold 5,479 shares at $2.3042 leaving 1,618,608 shares; and on 09/08/2025 it sold 11,686 shares at $2.2871 leaving 1,606,922 shares. The filing is signed by Sarah Bardo as trustee on 09/08/2025. The filing notes the reported prices are weighted averages and that detailed per-price quantities are available upon request.

Emerald Green Trust, acting as a director-related reporting person for Xos, Inc. (XOS), reported three scheduled sales of common stock executed under a Rule 10b5-1 trading plan adopted May 27, 2025. The sales occurred on 08/29/2025 (19,731 shares at a weighted average price of $2.8889), 09/02/2025 (24,593 shares at $2.6191) and 09/03/2025 (19,333 shares at $2.4764). Following these dispositions the reporting person beneficially owned 1,637,197 shares. The filings state the price ranges for each sale date and note that full per-price breakdowns are available upon request.

Emerald Green Trust, a reporting person identified as a director and 10% owner of Xos, Inc. (XOS), sold a total of 90,676 shares of XOS common stock across three transactions on 08/26/2025 (41,894 shares), 08/27/2025 (28,384 shares) and 08/28/2025 (20,398 shares). The disposals were effected under a previously established Rule 10b5-1 trading plan adopted May 27, 2025. Weighted average sale prices are reported for each date (approximately $3.02 to $3.04), and the reporting person states full price-by-price detail will be provided on request. After these sales, Emerald Green Trust beneficially owned 1,700,854 shares of XOS common stock.

Xos, Inc. disclosed two material items in an 8-K. First, on August 21, 2025 the company entered a Lease Termination Agreement for its 235,094 sq ft Mesa, Arizona manufacturing facility leased by subsidiary EMV Automotive USA Inc. The termination is contingent on the landlord securing a replacement tenant; if no replacement is found the lease remains in effect through its 2033 expiration.

Under the agreement Xos will pay approximately $2.7 million in monthly payments over 18 months after termination, forfeit a security deposit of ~$1.2 million, and pay leasing commissions of ~$1.3 million. Xos said it will continue using other manufacturing sites and does not anticipate operational impact. Second, as disclosed, on August 25, 2025 the company issued 1,803,262 shares to Aljomaih Automotive Company to satisfy ~$6.0 million of accrued interest on a convertible note, converted at the 10-day VWAP.

Xos, Inc. (XOS) filed a Form 144 notifying intent to sell 200,000 shares of Common Stock through Piper Sandler & Co. The filing lists an aggregate market value of $616,000 and reports 8,690,583 shares outstanding. The shares were acquired on 08/20/2021 as SPAC merger shares and the proposed approximate sale date is 08/26/2025. The filer reports no securities sold in the past three months and provides the standard representation that the seller is not aware of any undisclosed material adverse information. The filing does not include details on the seller's identity, reason for sale, or any trading plan dates.